NBTS is unlocking clinical trials & driving progress against #glioblastoma. In 2025, we ⭐ accelerated a Phase II trial for a promising #GBM vaccine ⭐ discovered a new vulnerability to launch a new clinical trial Give now to help us do even more in 2026: Braintumor.org/Impact

The NIHR have announced a £13.7m investment to establish a Consortium to transform outcomes for brain tumour patients in the UK. The Consortium will be co-led by Dr Richard Mair, one of our Brain Cancer Virtual Institute leads. Find out more: crukcambridgecentre.org.uk/NIHRBrainTum...

Excited to share I’ve received a #SSMF #Consolidator grant! 📣 Recruiting a #postdoc to study #cancer #neuroscience #3Dgenomics #multiomics #singlecellomics 🔬How neural inputs shape #3Dgenome and #cellplasticity in #glioblastoma #GBM Interested? Apply now 👇 rb.gy/m7xz7b

Happy to share a new #NORLUX study on how humanized patient-derived xenografts of #glioblastoma can be useful in investigating immunosuppression and clinically-relevant immunotherapy testing. See for more: www.biorxiv.org/content/10.1... #immunotherapy, #preclinicalmodeling,

RCSI welcomes the #ARCHubTherapeuticsLaunch, a €31.6m research initiative to fast-track biomedical innovation into real-world impact. RCSI will drive clinical and translational aspects of the Hub as a partner institution. 🔗 www.rcsi.com/dublin/news-... #RCSIdiscover #euinmyregion 🇮🇪🇪🇺

We're excited to host a distinguished lineup of speakers at @CellSymposia #CSHallmarks2026, including keynote speakers @johannajoyce.bsky.social & Faisal Mahmood @harvardmed.bsky.social. View the full speaker lineup: http://dlvr.it/TPbBqL

🗺️Recently, 4 of our students have been based in @rcsi.bsky.social. Mohannad was joined by Promise @mimetas.bsky.social Soumi @soumi07.bsky.social @institutducerveau.bsky.social & Aleksandr #GeneXplain who were completing academic secondments. We hope that you all had a great time in Dublin!🙏

We are honoured to welcome our new Member, Annette Byrne, professor of Physiology at the @rcsi.bsky.social and head of the RCSI Precision Cancer Medicine Group. Learn about #RIAAdmittanceDay 2025: www.ria.ie/2025/05/22/28-new-members-admitted-to-the-royal-irish-academy/

📣Read our 3rd newsletter & see what we have been up to recently! Find it here: www.glioresolve.eu/media-1 @institutducerveau.bsky.social @lih-luxembourg.bsky.social @erasmusmc.bsky.social @rcsi-research.bsky.social @uniheidelberg.bsky.social @viblifesciences.bsky.social @mimetas.bsky.social

🚨 Attention please! 🚨 The key dates for #EACR2026 are finally here — ✨ Abstract submission opens: 1 December 2025 ✨ Registration opens: 7 January 2026 Time to start preparing your research highlights, ideas — #EACR2026. A fantastic opportunity to connect with the global cancer research community. 🔬

Join our free webinar with @10xgenomics.bsky.social! Camilla Engblom: spatially resolving antigen receptors in tumour tissue Heidi Haikala: ex vivo modelling of the tumour immune microenvironment in lung cancer 📅 04 Dec, 15:00 CET us02web.zoom.us/webinar/regi...

Gain an introduction to the technology, data analysis, tools, and resources used in RNA sequencing and transcriptomics. Introduction to RNA-seq and functional interpretation will run virtually from 9 – 13 February 2026: www.ebi.ac.uk/training/eve... @ebi.embl.org @events.embl.org 🧬🖥️

Reminder: applications close for our single-cell RNA-seq with Python course next week. Course dates: 2 – 6 February 2026 Course fee: from £240.00, funding is available. Location: virtual, UK time zone Apply by 2 November 2025: www.ebi.ac.uk/training/eve... #Python #SingleCell #Bioinformatics 🧬📊🐍

🧠 A recent Quanta Magazine article presents a new generation of researchers, including Thomas Andrillon and Nicolas Decat from Paris Brain Institute, exploring the subtle dynamics of consciousness between sleep and wakefulness. 👉 https://urlr.me/8kgGq4

🚀 Join Dr. Marodon to explore 15 years of innovation in humanized mouse models — from 🧬 T cell repertoire development 🦠 HIV & gene therapy 🎯 Immune checkpoints in cancer 📅 Nov 20, 2025 | 🕓 16:00 CET / 10:00 EST 👉 Register here: lnkd.in/eRm3srWb

#EXCITINGNEWS Brain Tumor Meeting by the Sea, Second Edition, GOPA/PETRA/ANOCEF, March 23-25 2026, Palais des Congrès, Saint-Malo. #STAY_TUNED Program and registration coming soon.

📣 #SAVETHEDATE! - by #PETRANetwork November 24, 1:00-2:15pm, online, Manuel VALIENTE: “Exploiting microenvironment heterogeneity to challenge brain metastases in mice and human”. 📅 Monday, November 24 🕐 1.00 - 2.15pm ➡️ lnkd.in/d5W4ihJT ID: 953 4083 2452 Code: 249157

1️⃣ Treg Breakthrough: Nobel-Winning Cells Turned Against Brain Tumors 🧠✨ Galvez-Cancino et al. show that depleting Tregs in brain tumor models unleashes innate anti-tumor immunity — enabling antibody-dependent killing and reshaping the tumor microenvironment.

Listen to reflections from some of the PPI Ignite Network’s Public Advisory Panel (PAB). They reflect on the impact of the work personally and professionally. @hrbireland.bsky.social @researchireland.ie www.youtube.com/watch?v=7rF8...

🎗️ EANO proudly supports the 2025 International Brain Tumour Awareness Week! Let’s raise awareness, support patients, and promote advancements in research in #NeuroOncology. Together, we can make a difference! #EANO #BrainTumourAwareness #btsm #BrainTumours

🧠It’s #BrainTumourAwarenessweek where we shine a light on patients and families as well as on the research driving progress. #GLIORESOLVE seeks to find new treatment options for #glioblastoma patients through collaborative European research www.glioresolve.eu #MSCA @horizoneu.bsky.social

#EANO2025 in Prague has come to a close – what an inspiring meeting of science, learning, and collaboration! Thank you to all who contributed to this year’s success. Together we advance #NeuroOncology and improve care for people with brain tumours. #EANO #btsm

We are committed to tackling GBM through innovative research and collaboration. On #WorldCancerResearchDay, we celebrate the dedication of scientists and clinicians working to understand cancer, develop new therapies and improve patient outcomes. Together we push the boundaries of #cancerresearch

🧠 New study from MIMETAS & Roche (pRED) shows how the ApoE4 Alzheimer’s risk gene alters brain endothelial function & iron transport. Using our iPSC-based BBB model + Roche’s BrainShuttle tech, we uncovered ApoE4-driven changes that may shape how therapies can reach the brain. shorturl.at/RwgUP

A new clinical trial is recruiting patients with glioblastoma — the most aggressive brain tumor in adults. KSAT’s The Conversation talks to Dr. Andrew Brenner about the study and how patients can get involved. #Glioblastoma #ClinicalTrial #BrainCancerResearch youtu.be/5Vm95A-zVcE?...

📣 Join us in #Prague on 15 Oct for the GLIORESOLVE #EANO2025 satellite pre-meeting! Speakers: Prof Patrick Wen (Harvard), Prof Anna Dimberg (Uppsala), Prof Gabriele Bergers (VIB), Dr Kate Connor (TCD) plus research highlights from our PhD students. Details & registration: www.eano.eu/eano2025/pro...

Level up your science! Explore EMBL’s hands-on courses, conferences, and learn cutting-edge techniques from world-class experts. Here is the poster for 2026 #EMBL #EMBLEvents #LifelongLearning #ScienceTraining

Nanjing University is organizing "AI Augmented Biology," a conference in China on AI's integration with biological sciences. Topics include multi-modal data, protein engineering, and LLMs for biology. 🗓️ Oct 22-24, 2025 📍 Nanjing, China #AIinScience #Bioinformatics #Genomics #Conference

Google has introduced AlphaGenome, an AI model designed to predict the impact of genetic mutations on gene regulation across the human genome. This development aims to contribute to the understanding of disease mechanisms and potential therapeutic avenues. #AlphaGenome #AI #Genomics

On #GlioblastomaAwarenessDay, we reflect on lives affected by this devastating disease. In #GLIORESOLVE, we’re working to understand the complex landscape that surrounds and fuels each tumour — aiming for more personalised, effective treatments #BrainTumourResearch www.glioresolve.eu

More than 13,000 Americans will be diagnosed with #glioblastoma in 2025, yet treatments and survival rates have remained largely unchanged for decades. 📣 This #GBMDay, reshare these stats to raise public awareness and inspire action. Learn more: braintumor.org/events/gliob...

📣 Join us in #Prague on 15 Oct for the GLIORESOLVE #EANO2025 satellite pre-meeting! Speakers: Prof Patrick Wen (Harvard), Prof Anna Dimberg (Uppsala), Prof Gabriele Bergers (VIB), Dr Kate Connor (TCD) plus research highlights from our PhD students. Details & registration: www.eano.eu/eano2025/pro...

Join ICSB2025 in Dublin: The late-breaking abstract deadline has been extended to August 1st (for oral presentation) and September 1st (for posters). Hope to see you in Dublin! icsb2025.com

Happy to share our latest work by Verheul, Fabro etal, describing our optimized protocol for establishing GBM cell cultures. Another step forward to personalized drugscreening for GBM patients! Thank you to everyone who contributed.🙏𝗡𝗮𝘁𝘂𝗿𝗲 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆(2025) 🔗 www.nature.com/articles/s41...

This recent study maps the transcriptional heterogeneity of IDH-wildtype glioblastoma, identifying distinct cellular states and gene programs across disease stages: "The multilayered transcriptional architecture of glioblastoma ecosystems" doi.org/10.1038/s415...

It has long been known that glioblastoma(GBM) tumor microenvironment evolves; how therapy shapes the GBM TME remains poorly understood. This recent article sheds light on it: "Deciphering the longitudinal trajectories of GBM ecosystems by integrative single-cell genomics" doi.org/10.1038/s415...

📣 **SAVE THE DATE** The GLIORESOLVE consortium is hosting a satellite conference at #EANO2025 in Prague on 15 October. We have an outstanding lineup of invited speakers and exciting research updates from the network. Free registration will open soon via the EANO website. #BrainTumourResearch

Professor Annette Byrne, Professor of Physiology at RCSI and head of the RCSI Precision Cancer Medicine Group has been elected as a Member of the Royal Irish Academy, Ireland’s foremost body of experts in sciences and humanities. 🔗 tinyurl.com/4yx2auwx #RCSIdiscover

Congratulations again to GLIORESOLVE Coordinator Prof Annette Byrne who has been elected as a Member of the Royal Irish Academy. Read the RCSI press release here www.rcsi.com/dublin/news-... @physiologyrcsi.bsky.social @mariescurie-ire.bsky.social @horizoneu.bsky.social @researchireland.ie

Impressive de novo enzyme design! 🧪 Researchers engineered new protein catalysts for cyclopropanation (some >99:1 e.r.!) & Si-H insertion. They even used directed evolution in whole cells to optimize! Shows efficient catalysts are designable. #ProteinDesign www.science.org/doi/10.1126/...

How do enhancers drive cell specificity? 🤔 Fascinating study used 64k+ synthetic sequences in blood cell differentiation & found activating TF sites often show negative synergy, converting TF gradients into sharp gene patterns! #Bioinformatics www.cell.com/cell/fulltex...

Meet AutoBA: An autonomous AI agent simplifying complex multi-omic analysis! 🧬 Features LLM power, self-designing plans, online/local flexibility, Auto Code Repair, & adaptability to new tools. #bioinformatics #AI #genomics #LLM #AutoBA advanced.onlinelibrary.wiley.com/doi/full/10....

1/ Truly excited to share our new study that I had to privilege to co-lead during my PhD alongside great friends and collaborators @masashi-nomura.bsky.social, @kevin-johnson.bsky.social and Luciano Garofano, published at Nature Genetics @natureportfolio.nature.com! www.nature.com/articles/s41...

UNDERSTANDING AND TARGETING RESISTANCE in Glioblastoma (UNITE Glioblastoma) ist eine DFG geförderte Forschungsinitiative, Hier ein Interview mit Prof. Wolfgang Wick @wickwolfgang.bsky.social und Dr. Sophie Heuer im Rahmen der Reihe ÜBERLEBENSSTRATEGIEN: www.youtube.com/watch?v=BO3I...

Great paper focusing on the secondary use of health data in Ireland, exploring issues surrounding use of health data for purposes beyond patient care @rcsipophealth.bsky.social #healthdata #secondaryuse #scientificresearch

This recent paper explores how the ketogenic diet might have potential benefits on the progression of GBM patients. Check it here: doi: 10.3389/fnut.2024.1489812 #GBM #Glioresolve

🚀 New publication! We developed a PTPRZ1-specific TCR-T cell therapy for glioblastoma. 🔬 Key findings: ✅ Identified a PTPRZ1-reactive TCR from a vaccinated patient ✅ Kills glioblastoma cells with no off-target effects ✅ Eliminates tumors in murine brain models 🔗 www.nature.com/articles/s41...

The GLIORESOLVE project was featured in the 2024/2025 World Edition of the Brain Tumour Magazine, published by the @theibta.bsky.social You can read the full publication here issuu.com/ibta-org/doc... and our article is on Pg 23!

A new study from Nature suggests four novel gene expression programs in glioma-associated myeloid cells (💡): www.nature.com/articles/s41...

Researchers in preclinical toxicology—don’t miss this. Our latest webinar on 3D in vitro models for assessing new drug modalities is now available on demand. Learn how organ-on-a-chip tech is advancing predictive toxicology with real human relevance. Watch here: shorturl.at/caHUN